Protagonist Therapeutics, Inc.
NOVEL a4B7 PEPTIDE ANTAGONISTS
Last updated:
Abstract:
The invention relates to disulfide-rich peptide molecules which inhibit binding of .alpha.4.beta.7 to the mucosal addressin cell adhesion molecule (MAdCAM) in vivo, and show high selectivity against .alpha.4.beta.1 binding.
Status:
Application
Type:
Utility
Filling date:
22 Feb 2019
Issue date:
16 Jan 2020